These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 28528561)

  • 21. Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
    Tumlin JA; Murugan R; Deane AM; Ostermann M; Busse LW; Ham KR; Kashani K; Szerlip HM; Prowle JR; Bihorac A; Finkel KW; Zarbock A; Forni LG; Lynch SJ; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Bellomo R;
    Crit Care Med; 2018 Jun; 46(6):949-957. PubMed ID: 29509568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II Administration in Patients With COVID-19 Shock.
    Ofosu-Barko K; Liu Y; Alkhatib Tamimi F; Al Husami W; Ganatra S; Resnic F; Shah SP
    Crit Pathw Cardiol; 2021 Jun; 20(2):100-102. PubMed ID: 33031192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
    Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH
    Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the norepinephrine to angiotensin II conversion ratio in patients with vasodilatory hypotension: A post-hoc analysis of the ARAMIS trial.
    See EJ; Chaba A; Spano S; Maeda A; Clapham C; Liu J; Khasin M; Liskaser G; Eastwood G; Bellomo R
    J Crit Care; 2024 Feb; 79():154453. PubMed ID: 37890357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of angiotensin II as vasopressor in vasodilatory shock.
    Lumlertgul N; Ostermann M
    Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock.
    Bissell BD; Browder K; McKenzie M; Flannery AH
    Ann Pharmacother; 2018 Sep; 52(9):920-927. PubMed ID: 29582666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK.
    Priyanka P; Chang CH; Chawla LS; Kellum JA; Clermont G; Murugan R
    Shock; 2022 Oct; 58(4):260-268. PubMed ID: 36018286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilatory shock in the ICU and the role of angiotensin II.
    Wakefield BJ; Sacha GL; Khanna AK
    Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis.
    Smith LM; Mentz GB; Engoren MC
    Crit Care Med; 2023 Dec; 51(12):1674-1684. PubMed ID: 37378469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock.
    Leisman DE; Handisides DR; Chawla LS; Albertson TE; Busse LW; Boldt DW; Deane AM; Gong MN; Ham KR; Khanna AK; Ostermann M; McCurdy MT; Thompson BT; Tumlin JS; Adams CD; Hodges TN; Bellomo R
    Ann Intensive Care; 2023 Dec; 13(1):128. PubMed ID: 38103056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY.
    See EJ; Clapham C; Liu J; Khasin M; Liskaser G; Chan JW; Serpa Neto A; Costa Pinto R; Bellomo R
    Shock; 2023 May; 59(5):691-696. PubMed ID: 36930693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.
    Lamontagne F; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Rowan KM; Mouncey PR;
    JAMA; 2020 Mar; 323(10):938-949. PubMed ID: 32049269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW).
    Rurua M; Machavariani K; Sanikidze T; Shoshiashvili V; Pachkoria E; Ratiani L
    Georgian Med News; 2022 Feb; (323):157-161. PubMed ID: 35271489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial.
    Choong K; Bohn D; Fraser DD; Gaboury I; Hutchison JS; Joffe AR; Litalien C; Menon K; McNamara P; Ward RE;
    Am J Respir Crit Care Med; 2009 Oct; 180(7):632-9. PubMed ID: 19608718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
    Conrad M; Perez P; Thivilier C; Levy B
    J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.